Diffuse large B-cell lymphomas with aberrations in MYC, BCL2 and/or BCL6 by genetic
alterations or protein expression represent a group of high grade B-cell lymphomas with …

High-grade B-cell lymphomas (HGBLs) with MYC and BCL2 and/or BCL6 rearrangements,
so-called “double-hit” lymphomas (HGBL-DH), are aggressive lymphomas that form a …

Double-hit lymphoma (DHL) is a subgroup of aggressive lymphomas with both MYC and
BCL2 gene rearrangements, characterised by a rapidly progressing clinical course that is …

The 2016 revision of the World Health Organization (WHO) classification for lymphoma has
included a new category of lymphoma, separate from diffuse large B-cell lymphoma, termed …

Diffuse large B-cell lymphomas (DLBCL) are now considered a heterogeneous group of
distinct molecular subtypes (germinal center B-cell DLBCL, activated B-cell DLBCL, and …

High-grade B-cell lymphomas with MYC and BCL2 and/or BCL6 rearrangements (double-
/triple-hit lymphoma) have an aggressive clinical course. We investigated the prognostic …

Opinion statement The 2016 revision of the WHO classification of lymphoid neoplasms
includes new entities along with a clearer definition of provisional and definitive subtypes …

The management of diffuse large B-cell lymphoma (DLBCL) has been gradually evolving
since the discovery of its 2 major forms, the germinal center B-like (GCB) and activated B …

Background Salvage immunochemotherapy followed by high‐dose chemotherapy and
autologous stem cell transplantation is the standard‐of‐care second‐line treatment for …

The 2016 revised World Health Organization (WHO) classification of lymphoid malignancies
recognizes several distinct entities within the group of diffuse large B-cell lymphoma …